Today in Finance
SEE OTHER BRANDS

Your finance news reporter from the world

Today in Finance: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Finance.

Press releases published on May 6, 2025

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

‒ Q1 2025 Net Revenue of $39.1mm; Adjusted EBITDA of $23.6mm ‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time BERKELEY HEIGHTS, NJ., May 06, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on …

Zevra Therapeutics Announces Details for Q1 2025 Financial Results Call

Zevra Therapeutics Announces Details for Q1 2025 Financial Results Call

CELEBRATION, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced it will report corporate …

Caliber Enters Exclusive Development Agreement with Hyatt to Bring 15 Hyatt Studios Hotels to Key U.S. Markets

Caliber Enters Exclusive Development Agreement with Hyatt to Bring 15 Hyatt Studios Hotels to Key U.S. Markets

SCOTTSDALE, Ariz., May 06, 2025 (GLOBE NEWSWIRE) -- Caliber (NASDAQ: CWD), a real estate investor, developer, and manager, today announced that it has entered into a Development Rights Agreement with an affiliate of Hyatt Hotels Corporation (NYSE: H) to …

Bioventus Reports First Quarter Financial Results

Bioventus Reports First Quarter Financial Results

Q1 reported revenue of $123.9 million declined 4.3%; Organic* revenue advanced 5.0% First quarter net loss was $0.04 per share compared to a loss of $0.08 in the prior-year period Non-GAAP earnings* of $0.08 per share increased 33% Company reiterated …

Keiretsu Forum Mid-Atlantic and South-East Appoints Christian Haller as Regional Vice President, Signaling Strategic Leadership Expansion

Keiretsu Forum Mid-Atlantic and South-East Appoints Christian Haller as Regional Vice President, Signaling Strategic Leadership Expansion

PHILADELPHIA, May 06, 2025 (GLOBE NEWSWIRE) -- Keiretsu Forum Mid-Atlantic and South-East, a leading network for accredited angel investors and innovators, is proud to announce the appointment of Christian Haller as Regional Vice President. Haller’s role …

Sono Hits the Road: Confirmed Trade Show Appearances Across Europe in 2025

Sono Hits the Road: Confirmed Trade Show Appearances Across Europe in 2025

Munich, Germany, May 06, 2025 (GLOBE NEWSWIRE) -- The solar technology company Sono Group N.V. (OTCQB: SEVCF) (hereafter referred to as “Sono Group” or “Sono”, parent company to Sono Motors GmbH or “Sono Motors”) is pleased to announce its confirmed …

TINA.org Finds U-Haul Using Bait-and-Switch Pricing Scheme

TINA.org Finds U-Haul Using Bait-and-Switch Pricing Scheme

MADISON, CONN., May 06, 2025 (GLOBE NEWSWIRE) -- U-Haul is engaged in a bait-and-switch pricing scheme with its $19.95 truck rental ads, according to an investigation by consumer advocacy organization truthinadvertising.org (TINA.org). The ad watchdog has …

Neuronetics Reports First Quarter 2025 Financial and Operating Results

Neuronetics Reports First Quarter 2025 Financial and Operating Results

MALVERN, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of …

Sanofi: Investing in prevention builds Europe’s health and competitiveness

Sanofi: Investing in prevention builds Europe’s health and competitiveness

WARSAW, Poland, May 06, 2025 (GLOBE NEWSWIRE) -- As the Polish Presidency of the EU Council enters its final stage health policy remains central to Europe’s strategic agenda. At the European Economic Congress in Katowice, discussions reflected both the …

Kraig Biocraft Laboratories Successfully Completes March/April Production Cycle; May Production Now Underway

Kraig Biocraft Laboratories Successfully Completes March/April Production Cycle; May Production Now Underway

ANN ARBOR, Mich., May 06, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that it has successfully completed its March/April spider silk …

The Joint Corp. Strengthens Management Appointing  SVP Legal and SVP Operations and Patient Experience

The Joint Corp. Strengthens Management Appointing SVP Legal and SVP Operations and Patient Experience

- Franchising legal specialist Andra J. Terrell with 20 years of experience in global master, single-unit and multi-unit franchising; compliance strategy; and financing, mergers, acquisitions, and divestitures- - Franchise operations leader Eric Wyatt with …

Pasithea Therapeutics Reports Positive Pharmacodynamic Results Demonstrating Robust Target Engagement from its Ongoing Phase 1 Clinical Trial of PAS-004

Pasithea Therapeutics Reports Positive Pharmacodynamic Results Demonstrating Robust Target Engagement from its Ongoing Phase 1 Clinical Trial of PAS-004

-- PAS-004 shows up to 91% inhibition of pERK, confirming substantial target engagement -- -- One patient in cohort 4A with stage 4 KRAS G12R mutated pancreatic cancer achieves over 5 months of stable disease with tumor volume reduction of -9.8% -- MIAMI, …

Xometry Reports First Quarter 2025 Results

Xometry Reports First Quarter 2025 Results

Q1 revenue increased 23% year-over-year to a record $151 million driven by robust marketplace growth. Q1 marketplace revenue increased 27% year-over-year, a 700 basis point acceleration from Q4 2024, driven by strong U.S. enterprise growth. Q1 gross profit …

Mersana Therapeutics Announces Strategic Restructuring and Reprioritization Plan Focused on Advancing Emi-Le in Triple-Negative Breast Cancer

Mersana Therapeutics Announces Strategic Restructuring and Reprioritization Plan Focused on Advancing Emi-Le in Triple-Negative Breast Cancer

Cost-saving initiatives expected to extend company’s cash runway and support current operating plan commitments into mid-2026 Company to host conference call at 8:00 a.m. ET on May 15 to discuss business updates and first quarter 2025 financial results …

J & J Snack Foods Reports Fiscal 2025 Second Quarter Results

J & J Snack Foods Reports Fiscal 2025 Second Quarter Results

MOUNT LAUREL, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- J …

ARRAY Technologies, Inc. Reports Financial Results for the First Quarter 2025

ARRAY Technologies, Inc. Reports Financial Results for the First Quarter 2025

2025 First Quarter Highlights Revenue of $302.4 million Gross Margin of 25.3% Adjusted gross margin(1) of 26.5% Net income to common shareholders of $2.3 million Adjusted EBITDA(1) of $40.6 million Net income per basic and diluted share of $0.02 Adjusted …

Willis Lease Finance Corporation Reports First Quarter 2025 Financial Results

Willis Lease Finance Corporation Reports First Quarter 2025 Financial Results

Delivers Pre-Tax Income of $25.3 Million and Record Quarterly Revenue of $157.7 Million Declares Second Quarter 2025 Dividend of $0.25 Per Share COCONUT CREEK, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” …

Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025

Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025

DUBLIN, Ireland and CHICAGO, May 06, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Company), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both …

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will participate in the following May investor conferences: BofA Securities 2025 Healthcare Conference: Fireside chat on Tuesday, …

Beam Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

Beam Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

First Patient Dosed in the Phase 1/2 Study of BEAM-301 in Glycogen Storage Disease Type Ia, Beam’s Second Clinical Stage In Vivo Editing Program Updated Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Accepted for Presentation at the European …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service